TREAT-NMD were honoured to be invited to the Joint Heads of Medicines Agencies (HMA) and European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, held in Amsterdam on February 12th and 13th. The workshop brought together a diverse array of stakeholders, including representatives from patient registries, regulatory agencies, pharmaceutical companies, patients, healthcare professionals, academics, and health technology assessment bodies.
TREAT-NMD news
Illuminating Hope: TREAT-NMD’s Commitment to Rare Disease Day
In a world that often overlooks the challenges faced by those with rare diseases, Rare Disease Day serves as a beacon of hope, a day dedicated to raising awareness and advocating for change. With 300 million people worldwide grappling with rare diseases, the need for collective action is more crucial than ever.
Join TREAT-NMD Advisory Committee for Therapeutics (TACT) in Boston: A Call for Therapeutic Innovators
If you are ready to take your drug development program to the next level, we encourage you to join us in Boston for the upcoming TACT meeting. Seize this opportunity to engage with top-tier experts, refine your strategy, and propel your therapeutic innovation forward.
Unlocking the Future of Rare Diseases: TREAT-NMD at World Orphan Drug Congress USA 2024
TREAT-NMD is honoured to be a media partner for this years World Orphan Drug Congress USA 2024 being held at the Boston Convention & Exhibition Centre from April 23 to April 25, 2024.
Applications for the TREAT-NMD Masterclass Event 2024 are now OPEN!
We are now accepting applications for our Masterclass Event 2024 in Dubai, UAE. This event is primarily for healthcare professionals, clinical researchers and allied health providers working in the Middle East region.
TREAT-NMD Unveils Groundbreaking Programme to Revolutionise Rare Disease Treatment
TREAT-NMD are proud to announce the launch of the PaLaDIn project, an incredibly exciting and ambitious new project that aims to accelerate research, understanding and treatment for neuromuscular and other rare diseases.
